Blackstone Life Sciences V Access Fund, L.P. — Form D/A
Blackstone Life Sciences V Access Fund, L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2020-09-18. The offering totals $383.9M, of which $383.9M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2020-09-18
- Form: D/A
- Accession: 0001817675-20-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $383.9M
- Amount sold: $383.9M
- Minimum investment: $100K
- Investors: 1,883
- Date of first sale: 2020-07-06
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-370747
Issuer
- Name: Blackstone Life Sciences V Access Fund, L.P.
- CIK: 0001817675
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: ONE GRAND CENTRAL PLACE, NEW YORK, NY, 10165
- Phone: 212-994-7400
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Scott L Huff | Executive Officer | Wilmington, DE |
| N/A NA iCapital Alternative Investments LLC | Executive Officer | New York, NY |
| Barbra E Kocsis | Executive Officer | New York, NY |
| N/A NA Maples Fiduciary Services (Delaware) Inc. | Executive Officer | Wilmington, DE |
| Edward L Truitt, Jr. | Executive Officer | Wilmington, DE |
| N/A NA Asterion Fund Services L.L.C. | Promoter | Wilmington, DE |
Other filings by this issuer (1)
More